PDX models derived from treatment‑refractory diffuse large B‑cell lymphoma (DLBCL) and MYC‑driven triple‑negative breast cancer (TNBC) responded similarly, showing median tumor‑volume reductions of 68 % and 55 %, respectively. Notably, a “MYC‑signature score” derived from RNA‑seq of the PDX tumors predicted response magnitude (R² = 0.78).
| Milestone | Expected Date | Key Improvements | |-----------|----------------|-------------------| | (512 qubits, 5 nm ASIC) | Q4 2027 | Double quantum bandwidth, 15 % lower power. | | IPZZ‑137‑X (Fully error‑corrected, logical qubits) | Q2 2028 | Logical error < 10⁻⁴, supports fault‑tolerant algorithms. | | IPZZ‑137‑Cloud (Managed service) | Q4 2028 | Multi‑tenant access via major cloud providers, SLA‑backed. | | IPZZ‑137‑AI‑Edge (Miniaturized 2 U module) | Q1 2029 | Targeted at autonomous‑vehicle fleets and edge data centers. | ipzz-137
IPZZ‑137 ships with , an extension of standard C++ that introduces quantum kernels ( qkernel ) and hybrid data structures ( qvector ). The QuantumPulse SDK also includes: | IPZZ‑137 ships with , an extension of